Qualcomm is suing a Chinese smartphone maker backed by online-shopping giant Alibaba Group Holding, in the latest patent-infringement case involving technology companies.
The US chip maker said it has filed a complaint in a Beijing court against Meizu Technology Co. over its alleged violation of intellectual property.
Qualcomm’s litigation against Meizu, in which Alibaba holds a stake, is part of the US company’s attempt to protect its licensing business in the world’s largest smartphone market, where it has faced regulatory challenges in recent years including an antitrust investigation by Beijing. Since Qualcomm reached a settlement with Chinese authorities last year and agreed to pay a fine, the chip maker has signed patent-licensing agreements with a number of Chinese clients, including Huawei Technologies Co. and Xiaomi Corp.
“Meizu is choosing to use [Qualcomm’s] technologies without a license, which is not only unlawful, but is unfair to other licensees that are acting in good faith and respectful of patent rights, and ultimately damaging to the mobile ecosystem and consumers,” said Don Rosenberg, executive vice president and general counsel of Qualcomm, in a statement.
Full Content: NY Post
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Chamber of Commerce Sues to Overturn FTC Non-Compete Ban
Apr 24, 2024 by
CPI
FTC Chief Warns of Healthcare Price Fixing Risks Amid Tech Advancements
Apr 24, 2024 by
CPI
Amazon’s Investment in Anthropic Faces Antitrust Scrutiny
Apr 24, 2024 by
CPI
Italian Antitrust Authority Fines Amazon €10 Million for Unfair Trade Practices
Apr 24, 2024 by
CPI
Tuta Mail Raises Alarm Over Google Search Ranking Plunge Amidst DMA Rollout
Apr 24, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI